133 related articles for article (PubMed ID: 17716774)
1. Avoidance of ACE inhibitors or angiotensin receptor blockers among women of childbearing potential with diabetes.
Guirguis AB; Shilliday BB; Malone RM; Pignone MP
Diabetes Res Clin Pract; 2008 Jan; 79(1):e11-2. PubMed ID: 17716774
[No Abstract] [Full Text] [Related]
2. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
3. [Adverse effects of ACE inhibitors, ARB, diuretics, and alpha1 blockers].
Shimamoto K
Nihon Rinsho; 2007 Oct; 65 Suppl 8():159-64. PubMed ID: 18074532
[No Abstract] [Full Text] [Related]
4. NSAIDs, ACE inhibitors, angiotensin II receptor antagonists, and isotretinoin: still too many pregnant women exposed.
Prescrire Int; 2010 Feb; 19(105):25. PubMed ID: 20455339
[No Abstract] [Full Text] [Related]
5. [Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers].
Roskiewicz F; Andriamanana I; Gras-Champel V; Andrejak M; Massy ZA
Nephrol Ther; 2007 Jun; 3(3):89-95. PubMed ID: 17540310
[TBL] [Abstract][Full Text] [Related]
6. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes.
Ceriello A
Curr Opin Lipidol; 2006 Oct; 17(5):510-8. PubMed ID: 16960499
[TBL] [Abstract][Full Text] [Related]
7. [Role of oxidative stress in diabetic vascular complications].
Inoguchi T; Takayanagi R
Fukuoka Igaku Zasshi; 2008 Mar; 99(3):47-55. PubMed ID: 18536327
[No Abstract] [Full Text] [Related]
8. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin receptor blockers and myocardial infarction: results reflect different cardiovascular states in patients with types 1 and 2 diabetes.
Lewis EJ;
BMJ; 2005 May; 330(7502):1269-70; author reply 1270-1. PubMed ID: 15920133
[No Abstract] [Full Text] [Related]
10. Cutaneous adverse effects of angiotensin-II receptor antagonists.
Prescrire Int; 2007 Feb; 16(87):21. PubMed ID: 17326283
[TBL] [Abstract][Full Text] [Related]
11. The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.
Mathur G; Noronha B; Rodrigues E; Davis G
Diabetes Obes Metab; 2007 Sep; 9(5):617-29. PubMed ID: 17697055
[TBL] [Abstract][Full Text] [Related]
12. Hypertension management in outpatient visits by diabetic patients.
Aparasu RR; Aparasu A
Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038
[TBL] [Abstract][Full Text] [Related]
13. Teratogen use in women of childbearing potential: an intervention study.
Morrical-Kline KA; Walton AM; Guildenbecher TM
J Am Board Fam Med; 2011; 24(3):262-71. PubMed ID: 21551398
[TBL] [Abstract][Full Text] [Related]
14. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
Abuissa H; O'Keefe J
Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
[TBL] [Abstract][Full Text] [Related]
15. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
16. IgA nephritis--ACE inhibitors, steroids etc?
Wardle EN
Nephrol Dial Transplant; 2007 Jun; 22(6):1785; author reply 1785. PubMed ID: 17403702
[No Abstract] [Full Text] [Related]
17. Drug-induced hyperkalaemia is frequent.
Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17323523
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece.
Symvoulakis EK; Kyrmizakis DE; Drivas EI; Bizakis J; Velegrakis GA; Lionis C
Eur J Gen Pract; 2007; 13(4):239-41. PubMed ID: 18324507
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin II type 1 receptor blockade and risk of cancer].
Madsen FF
Ugeskr Laeger; 2010 Nov; 172(44):3054; discussion 3054. PubMed ID: 21086708
[No Abstract] [Full Text] [Related]
20. ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery.
Knobloch K; Gohritz A; Spies M; Vogt PM
Interact Cardiovasc Thorac Surg; 2008 May; 7(3):475-6; author reply 476. PubMed ID: 18495720
[No Abstract] [Full Text] [Related]
[Next] [New Search]